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Alterations in dopamine neurotransmission are generally associated with diseases such 
as attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder 
(OCD). Such diseases typically feature poor decision making and lack of control on 
executive functions and have been studied through the years using many animal models. 
Dopamine transporter (DAT) knockout (KO) and heterozygous (HET) mice, in particular, 
have been widely used to study ADHD. Recently, a strain of DAT KO rats has been 
developed (1). Here, we provide a phenotypic characterization of reward sensitivity and 
compulsive choice by adult rats born from DAT–HET dams bred with DAT–HET males, 
in order to further validate DAT KO rats as an animal model for preclinical research. 
We first tested DAT KO rats’ sensitivity to rewarding stimuli, provided by highly appetitive 
food or sweet water; then, we tested their choice behavior with an Intolerance-to-Delay 
Task (IDT). During these tests, DAT KO rats appeared less sensitive to rewarding stimuli 
than wild-type (WT) and HET rats: they also showed a prominent hyperactive behavior 
with a rigid choice pattern and a wide number of compulsive stereotypies. Moreover, 
during the IDT, we tested the effects of amphetamine (AMPH) and RO-5203648, a trace 
amine-associated receptor 1 (TAAR1) partial agonist. AMPH accentuated impulsive
behaviors in WT and HET rats, while it had no effect in DAT KO rats. Finally, we measured 
the levels of tyrosine hydroxylase, dopamine receptor 2 (D2), serotonin transporter, and 
TAAR1 mRNA transcripts in samples of ventral striatum, finding no significant differences 
between WT and KO genotypes. Throughout this study, DAT KO rats showed alterations 
in decision-making processes and in motivational states, as well as prominent motor 
and oral stereotypies: more studies are warranted to fully characterize and efficiently use 
them in preclinical research.
 
Keywords: Intolerance-to-Delay Task, sucrose consumption, appetitive food eating, reward sensitivity, behavioral 
rigidity
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INTRODUCTION
Brain dopamine (DA) is closely involved in the modulation 
of several neurobiological and behavioral processes, including 
decision making, reward processing, motivational states, habits, 
and movement control. Dysregulation in forebrain dopaminer-
gic signaling and function is associated with many neurological 
and neuropsychiatric diseases, such as schizophrenia (SZ), 
attention-deficit/hyperactivity disorder (ADHD), obsessive-
compulsive disorder (OCD), and Parkinson disease (PD) (2–5). 
Encoded by the SLC6A3 gene, dopamine transporter (DAT) has 
a key role in reuptake; therefore, its activity is fundamental for 
a correct regulation of dopaminergic pathways. The importance 
of DAT activity in DA circuitry is supported by the effects of 
many drugs of abuse and neurotoxins; current pharmacological 
therapeutic strategies for diseases like ADHD or a major depres-
sion involve drugs such as psychostimulants or triple reuptake 
inhibitors (6–8).
Psychostimulants such as amphetamine (AMPH) or meth-
ylphenidate can, however, have an effect also on trace amine-
associated receptor 1 (TAAR1), another protein that has a 
significant role in DA neurotransmission. TAAR1 is a G protein-
coupled receptor that colocalizes with DAT, has close interactions 
with it, and can modulate its activity when activated (9, 10). At 
the same time, TAAR1 modulates D2 DA receptor function likely 
due to heterodimerization (11, 12). Intriguingly, altered levels of 
trace amines have been associated with many diseases, including 
ADHD. Moreover, it has been suggested that most of the effects 
of psychostimulants may be modulated by influencing TAAR1 
activity (13, 14). TAAR1 is therefore proposed as a target for 
new medications, and various compounds are under preclinical 
development. Research in this field needs to move across preclini-
cal studies in animal models, and this allows direct insights into 
the neurobiological, genetic, and biopsychological functioning, 
in the aforementioned mental diseases.
Several of the main features issuing from an impairment 
of DAT activity in humans have been studied using the DAT 
knockout (KO) mouse (15–17). Since first generated, DAT KO 
mice have been used in a wide range of studies, thanks to their 
peculiar behavioral phenotype. Specifically, in addition to early 
life mortality, the DAT KO mice show hyperactivity, cognitive 
deficits, sleep dysregulation, and a low behavioral inhibition. 
They also have relevant alterations in dopaminergic tone within 
frontostriatal circuits and in the striatal expression of many 
proteins, such as D1 and D2 receptors and tyrosine hydroxylase 
(TH). Finally, they also show a paradoxical reduction of loco-
motor activity after AMPH treatment [see (17–19)]. Because of 
such features, DAT KO mice have been extensively used as a 
model of ADHD, a widespread neurodevelopmental disorder 
affecting up to 2–5% of infants and adolescents and persisting 
into adulthood (20, 21).
Well known to be comorbid with other diseases such as major 
depression and bipolar disorder (22), ADHD has reportedly 
been associated with many other psychiatric disorders such as 
behavioral addictions, OCD, oppositional defiant disorder, and 
conduct disorder (CD) (23), all of which share common symp-
toms such as poor decision making and impaired impulse control. 
DAT KO mice, however, have proven useful also in understand-
ing many other neuropsychological diseases, like SZ (24, 25) 
or bipolar disorder (26). Recently, DAT KO mice have been 
used to model human DAT deficiency syndrome (DTDS), also 
known as early PD, a rare Parkinsonian-like movement disorder. 
DTDS’ symptoms can range from dystonic muscle contractions 
to bradykinesia, postural instability, and hypomimia: these are 
believed to be caused by an impaired DAT functionality, due to 
mutations in the SLC6A3 gene (27–30). It should be noted that 
due to the extreme phenotype of DAT KO mice, which could 
influence or even impair some behavioral measures, they have 
been avoided in some recent studies in favor of heterozygous 
(HET) DAT hypofunctional mice. These mice show milder but 
clear behavioral alterations, especially during adolescence: such 
phenotype consists of a motor hyperactivity, attentional deficits, 
impulsive behaviors, and an AMPH-mediated rescue, consistent 
with the construct of ADHD (31, 32).
Recently, Gainetdinov et  al. developed a novel DAT KO 
rat model that could provide a good translational model for 
ADHD as well as other human diseases involving alterations 
in DA circuitry. Their first work on DAT KO rats (1) showed 
increased extracellular DA concentrations, hyperactivity and 
cognitive deficits, as well as dysregulation in frontostriatal 
BDNF function. More in detail, DAT KO rats develop normally 
but weigh less than HET and wild-type (WT) rats, have a pro-
nounced spontaneous hyperactivity, and demonstrate a deficit 
in working memory and in sensori-motor gating. While striatal 
extracellular DA concentrations are significantly increased, 
the total tissue content of DA is markedly decreased (1). The 
hyperactivity of DAT KO rats can be counteracted by AMPH, 
methylphenidate, and a few other compounds, as well as by 
transient DAergic rearrangement typical of adolescent age (33). 
Here, we provide evidence of other behavioral alterations affect-
ing reward processing, decision making, and impulse control 
in DAT KO rats. First, we tested whether DAT KO rats have an 
abnormal sensitivity to rewarding stimuli, and then we tested 
their cognitive impulsivity through the use of the Intolerance-
to-Delay Task (IDT). Finally, we measured the basal gene 
expression in ventral striatum to check whether DAT KO rats 
have a different expression of genes associated with monoam-
inergic signaling.
The IDT is an operant task that involves a choice between 
either an immediate small reward or a delayed larger reward 
(in the form of smaller or larger quantities of food), extensively 
used to study behavioral impulsivity in rodents (34). The two 
options are calibrated so that the first one gives an immediate 
benefit, but is suboptimal in terms of payoff (i.e., global food gain), 
while the latter gives an overall optimal benefit throughout the 
whole task (35, 36). Through the process of temporal discounting, 
increasing the delay associated with the larger reward results in 
a progressive shift of preference from the larger to the smaller 
reward; subjects with a higher cognitive impulsivity tend to shift 
their preference even with short delays while subjects persisting 
on large-reward choice despite suboptimal payoff may be labeled 
as compulsive (35–38). We also studied the effects of AMPH and 
of a partial TAAR1 agonist drug during the execution of the IDT 
as a function of DAT genotype.
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MATERIALS AND METHODS
All experimental procedures were approved by the Italian 
Ministry of Health (formal license 5/2014-B, to GL). Procedures 
were in close agreement with the European Community Council 
Directive (2010/63/EEC) and Italian law. All efforts were made 
to minimize animal suffering, to reduce the number of animals 
used, and to utilize alternatives to in vivo techniques, if available.
Subjects
A total of 39 adult (8-month-old) male rats (with a Wistar Han 
background), of which 10 were WT (average body weight 530 g), 
17 HET (average body weight 530 g), and 12 DAT KO (average 
body weight 305  g), were used. These animals were obtained 
from Istituto Italiano di Tecnologia (IIT) (Genova, Italy), with 
the purpose of setting a colony at Istituto Superiore di Sanità 
(ISS) (Rome, Italy). Animals were born in IIT from the breed-
ing of DAT–HET males and females, weaned on PND 21 and 
shipped to ISS at adult age, where they were housed in pairs 
within Makrolon® III cages with sawdust bedding and with food 
and water ad libitum. No more than a pair of sibling subjects per 
genotype was chosen to be shipped, in order to avoid possible 
genetic biases. All dams being DAT–HET and all three genotypes 
being represented in each litter, there is no risk of biases due to dif-
ferential maternal behavior. They were kept in an air-conditioned 
room (temperature 21 ± 1°C, relative humidity 60 ± 10%), on a 
12-h reversed light–dark cycle (lights off at 07:00 a.m.) until the 
start of the experimental protocols.
During the first week, a cohort of 24 subjects (8 WT, 8 HET, 
and 8 KO) was randomly selected, and they underwent a test to 
measure their preference for a sweet solution compared to water 
and a test to study their behavior when exposed to a highly appe-
titive food. Rats were housed individually within Makrolon® III 
cages with sawdust bedding for the duration of these procedures 
only. Afterward, all 39 rats were tested in an IDT, for a total of 
6 weeks of testing. During this experimental protocol, a food 
restriction, to keep subjects at 95% (±2%) of their body weight, 
was imposed through a limited quantity of extra food given at the 
end of each IDT free-feeding experimental session. This strategy 
was applied to increase the animals’ motivation to work for food 
delivery at the beginning of each session.
Body Weight and Food Consumption
Body weight was measured thrice in a 2-week span before the 
start of the experimental protocols. Food consumption was 
measured during the same 2 weeks, by weighing the food pellet 
present in each home cage tray every 2 days. During the IDT, 
subjects’ body weight was measured three times per week, for the 
whole duration of the experimental protocol, in order to monitor 
and to titrate the level of food restriction.
Exp. 1: Preference for a Sweet Solution
During 4 days of testing, each rat had free access to two different 
bottles in its home cage, one containing water and one contain-
ing a sucrose solution (14%). The starting position of each bottle 
was counterbalanced, and each day the position of the bottles 
was swapped. The amount of fluid intake was measured for each 
subject by weighing each bottle every day at the same hour, with 
a Kern 440-49 N balance (Kern & Sohn, Balingen, Germany).
Exp. 2: Exposure to a Highly Appetitive 
Food
During 4 days of testing, twice per day (10:30 a.m. and 12:00 p.m.), 
each rat received 4.5 g of mascarpone cheese in its home cage, 
delivered inside baking paper cups and left on the cage floor for 
10 min. After this time, both baking cups and remaining cheese 
were removed with the quantity of remaining cheese and the con-
dition of the baking cups being measured. The remaining cheese 
was quantified as “all,” “more than half,” “less than half,” “none.” 
The condition of the cups was classified as “present” if it was left 
intact, and “deteriorated” or “absent” if it was destroyed or eaten.
Exp. 3: Intolerance-to-Delay Task
Apparatus
Eight operant panels (HOPs, PRS Italia, Rome, Italy) were each 
placed in a Makrolon® III cage with sawdust bedding: therefore, 
the apparatus consisted of standard cages identical to the sub-
jects’ home cages. The panels, which occupied one quarter of 
the living area, were provided with two nose-poking holes; two 
hole lights, placed inside each nose-poking hole; one feeding 
magazine where precision food pellets (45 mg, F0021, BioServ, 
Frenchtown, NJ, USA) were dropped, placed centrally between 
the nose-poking holes; one magazine light; one main chamber 
light, placed at the top of the panel; one hidden-feeding device 
that released food pellets into the magazine. Operant panels were 
connected through an interface to a computer. The whole task 
procedure was monitored and recorded through software (Sk020, 
PRS Italia, Rome, Italy).
Procedure
Subjects were tested for 5 days per week between 10:00 a.m. 
and 14:00 p.m., for a total of 15 training and 15 test sessions 
performed during a 6-week span. Each rat was tested in the 
same chamber at the same hour, and sessions lasted for 40 min. 
During each session, subjects could nose-poke into either of the 
two holes to release pellets in the magazine. Nose-poking in one 
hole [termed small and soon (SS)] resulted in the immediate 
delivery of one pellet in the magazine, whereas nose-poking 
in the other hole [termed large and late (LL)] resulted in the 
delivery of five pellets in the magazine after a set delay, whose 
length was 0  s during training, 15  s during test week 1, 30  s 
during test week 2, and 45  s during test week 3. Lights were 
used as visual cues: the main light was on to signal whenever 
the panel could be activated by a nose-poke; the hole lights were 
switched on just after a nose-poke in the corresponding hole for 
1 s until food delivery. After any food delivery, the panel entered 
a timeout (TO) of 30 s, during which additional nose-poking 
was recorded but was without any consequence (inadequate 
nose-pokes); the magazine light was kept switched on for the 
entire duration of the TO.
Training Phases (First 3 Weeks of IDT)
During a first “2vs2” training phase (on the first week of IDT 
testing), nose-poking in either hole resulted in the immediate 
4Cinque et al. DAT KO Rats Model for ADHD/OCD
Frontiers in Psychiatry | www.frontiersin.org February 2018 | Volume 9 | Article 43
release of two pellets. This phase was used to let subjects familiar-
ize with the apparatus with no reason to prefer any of the two 
holes. During the second “1vs5” training phase (on the second 
and third weeks of IDT testing), SS nose-pokes resulted in the 
release of one pellet, whereas LL nose-pokes resulted in the 
release of five pellets (but with a delay of 0 s). This phase allowed 
subjects to reach a clear preference for LL. During this phase, 
two animals did not reach a preference for LL; thus, they were 
excluded from data analysis.
Drugs
We used d-AMPH (1 mg/kg i.p. dissolved in saline solution) 
and RO-5203648 (39), a partial agonist of TAAR1 receptors, 
obtained from F. Hoffmann la Roche Ltd., Basel, Switzerland 
(1 mg/kg i.p. dissolved in a vehicle, i.e., DMSO 1% in distilled 
water). During 1vs5 training phase, every subject received saline 
i.p. before each session. During the three testing weeks, on the 
first day of every test week (Monday), every subject received 
saline i.p. before the session. The following 4  days of every 
test week (Tuesday–Friday), before each session, every subject 
received one of the following: saline, DMSO 1%, AMPH, or 
RO-5203648.
Amphetamine or saline was injected 15 min before session 
start, and RO-5203648 or vehicle was injected 10 min before 
session start. Therefore, both drugs had their peak effect 
during the middle of sessions. AMPH and RO-5203648 were 
administered on random days, but never administered on 
subsequent days; this produced eight different combinations of 
administration order during a test week, which was randomly 
assigned to subjects. Each combination was used on average on 
five subjects (at least one for each genotype), counterbalancing 
between genotypes to minimize any bias related to a specific 
administration order.
Genotyping by RFLP
The WT, DAT–HET, and DAT KO genotypes were checked on 
purified DNA by restriction fragment length polymorphisms 
(RFLPs): indeed, while the WT allele has one BtsIMutI restric-
tion site, this was specifically canceled in the KO allele (1). The 
DNA of each sample was extracted from a piece of tail of each rat, 
using the Dneasy Blood & Tissue Kit (QIAGEN) according to the 
manufacturer’s protocol. The target region was amplified using 
the following primer sequences: forward 5'-TCC TGG TCA 
AGG AGC AGA AC-3' and reverse 5'-CAC AGG TAG GGA 
AAC CTC CA-3'. These primers and the enzyme BtsIMutI (New 
England BioLabs, Ipswich, MA, USA) were used to identify the 
genotypes.
PCR amplification was performed in a 50-µl reaction volume. 
After the initial denaturation at 94°C for 15 min, there were 35 
cycles at 95°C for 30 s, 58°C for 30 s, and 72°C for 30 s, and then a 
final extension step of 72°C for 5 min. The DNA was substituted 
with sterile deionized water for the negative control. The PCR 
products were resolved on 2% agarose gel and identified by Novel 
Juice (GeneDirex) staining. For the genotypes analysis, 10  µl 
of the PCR products was digested for 1 h at 55°C with 1 µl of 
BtsIMutI (10 U/μl) in separate tubes. The cleaved products were 
resolved on 2.5% agarose gel.
RT-PCR and Ex Vivo Markers
Two weeks after the last behavioral test, 10 WT and 12 KO 
rats were sacrificed in a random order through decapitation 
in two consecutive days between 10:00 a.m. and 12:00 p.m. 
Brains were quickly removed and dissected on ice with single-
use metal scalpels. A 1-mm thick slice of ventral striatum was 
collected from each brain, with slices immediately stored in 
1.5-ml Eppendorf tubes containing 500 µl of RNA stabilization 
reagent RNAlater (QIAGEN). Samples were taken specifically 
from the ventral striatum as extensive neurochemical analyses 
already confirmed the expected changes within the dorsal 
striatum (1).
Samples were stored at −80°C until processed. Samples were 
processed to extract the total RNA using Rneasy Mini Kit 
(QIAGEN) according to manufacturer’s recommended protocol. 
Briefly, samples were solubilized and homogenized in RLT lysis 
buffer, loaded in columns containing silica membranes and sub-
jected to washing and centrifugation processes. RNA was eluted in 
100-µl volume and snap-frozen at −80°C. The concentration and 
purity of RNA samples were determined using a NANODROP 
2000 (Thermo Scientific).
The cDNA for each sample was obtained using RT2 First 
Strand Kit (QIAGEN) following producer’s recommended 
protocol. The RNA quantity for each sample was adjusted to 
5 ng/µl. Afterward, any genomic contamination was removed 
by mixing 8 µl from each sample (total of 40-ng RNA) with 
2  µl of genomic DNA elimination buffer (QIAGEN) and 
incubating at 42°C for 5 min. Finally, the retrotranscription 
was performed on each sample: 10  µl of each sample was 
mixed with 10  µl of Oligo(dT) retrotranscription mix and 
incubated at 42°C for 15 min and at 95° for 5 min in a T100 
(BIO-RAD) thermocycler. In the same way, negative retrotran-
scription controls (without retrotranscriptase enzyme) were 
performed. cDNA samples were then loaded in a total of six 
custom 96-well RT-PCR plates (QIAGEN). Each of the first six 
rows of each plate was used for a different assay: TH, TAAR1, 
Slc6a4 serotonin transporter (SERT), DRD2 (D2), plus the two 
housekeeping genes 18SrRNA and β-actin. The last two rows 
were used as positive and negative controls. Each sample was 
assayed in triplicate; thus, a total of four samples were assayed 
on each plate. Each well was loaded with 25  µl of solution 
containing 11.5 µl of water, 12.5 µl of SYBR Green (QIAGEN) 
mastermix, and 1 µl of cDNA. Amplification was carried out 
in an ABI 7500 (Applied Biosystem) thermocycler with the 
following conditions: 95°C for 15 min, followed by 40 cycles 
(95°C for 15 s and 60°C for 1 min), after the amplification, a 
melting curve was obtained.
Behavioral and Molecular Data Analysis
Data were analyzed using repeated measures analysis of 
variance. For food consumption, we used a one-way model, 
where the dependent variable was the total food intake and 
the factor was three-level genotype (WT vs HET vs KO). For 
preference for a sweet solution, we used a one-way model where 
the dependent variable was the percentage of a sweet solution 
intake over the total fluid intake and the factor was three-level 
FIGURE 1 | The average body weight measured for the three genotypes. Knockout (KO) rats weigh significantly less when compared to both wild-type (WT)  
and dopamine transporter–heterozygous (HET) rats. *P < 0.0001.
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genotype (WT vs HET vs KO). For the exposure to a highly 
appetitive food, we used a logistic multinomial regression for 
the quantity of cheese and a logistic regression for the cup con-
dition. For IDT, we used a split-plot model, and the factors were 
three-level genotype (WT vs HET vs KO) × four-level treat-
ment (Sal vs DMSO vs Amph vs RO-5203648) × three-level 
delay (15 vs 30 vs 45 s). Statistical analysis was performed using 
StatView II (Abacus Concepts, CA, USA). Data are expressed as 
mean ± SEM. Significance level was set at P ≤ 0.05, NS = not 
significant. Multiple post hoc comparisons were performed with 
Tukey’s HSD test.
RT-PCR curves were analyzed using ABI 7500 software 
v2.0.6. Quantification was carried out measuring the number of 
amplification cycles needed to cross a 0.04 fluorescence threshold 
(Ct). Melting curve analysis was then carried out to validate the 
purity of amplification products, and any replica with multiple 
or abnormal melting temperature was excluded from analysis. 
For TH, SERT, and D2 genes the cutoff was fixed at 37 cycles. 
Because of the extremely weak expression of TAAR1, the cutoff 
was fixed at 39 cycles for such gene. Data for TH, TAAR1, Slc6a4, 
and Drd2 genes were normalized to the mean of 18SrRNA and 
β-actin genes for each sample. The relative expression of each 
gene transcript was obtained using ΔΔCt and converted in the 
relative expression ratio (2−ΔΔCt). The statistical analysis was per-
formed using Microsoft Excel on normalized expression levels of 
WT vs KO samples. Significance was assessed using a two-tails 
Student’s t-test. Significance level was set at P ≤ 0.05, NS = not 
significant.
RESULTS
Body Weight and Food Consumption
According to the measures, the weight of KO rats (308 ± 5 g) 
is significantly lower, when compared to both WT (535 ± 9 g) 
and DAT–HET (532 ± 6 g) rats: F[2, 36] = 130.178, P < 0.0001 
(Figure  1). The weight difference was confirmed during the 
whole set of procedures.
Nevertheless, there were no significant differences bet-
ween genotypes when considering ad  libitum food intake: 
F[2, 21] = 0.283, P = NS.
Preference for a Sweet Solution
Though there were no significant differences between geno-
types when considering the total fluid intake, F[2, 21] = 0.129, 
P = NS, KO rats showed a markedly lower preference for the 
bottle containing a sweet solution, compared to WT and DAT–
HET: F[2, 21] = 24.216, P < 0.0001 (Figure 2).
Exposure to a Highly Appetitive Food
Multinomial logistic regression analysis showed that KO 
rats have a higher chance to eat less cheese when compared 
to both WT and DAT–HET. Considering the four categories 
for the quantification of the remaining cheese after 10 min 
(“all,” “more than half,” “less than half,” “none”), KO had a 
higher chance to leave “all” the cheese compared to leave 
“none” (P < 0.05) and a higher chance to leave “more than a 
FIGURE 2 | Proportion of the fluid intake from a bottle containing 14% sucrose over tap water. Preference for the sucrose bottle is significantly lower for knockout 
(KO) rats when compared to both wild-type (WT) and dopamine transporter–heterozygous (HET) rats. *P < 0.0001.
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half ” compared to leave “none” (P < 0.05), when compared to 
both WT and DAT–HET. Logistic regression analysis showed 
that KO rats have a higher chance to destroy the paper cups 
containing the cheese, when compared to both WT and DAT–
HET. Considering the categories for the state of paper cups 
after 10 min (“present” or “deteriorated”/“absent”), KO had a 
higher chance to destroy the cups (P < 0.05), when compared 
to both WT and DAT–HET.
Intolerance-to-Delay Task
Training: two KO rats were excluded from statistical analysis, 
as they did not reach a preference for LL; instead, they showed 
a high and stable preference for SS throughout the whole 
training phase. There was an overall significant difference in 
total nose-pokes between KO (211 ± 62) and the other two 
groups (WT: 154 ± 8; DAT–HET: 154 ± 11): F[2, 12] = 2.055, 
P < 0.05.
Latency
Knockout rats showed a higher latency to approach SS in each ses-
sion, when compared to WT and DAT–HET: F[2, 34] = 12.351, 
P < 0.0001. This difference was not present when considering 
latency to approach LL. There was a significant effect of delay on 
latency: for all three genotypes, at higher delays, there was a trend 
toward reduction of the latency to approach SS: F[2, 68] = 2.834, 
0.05 < P < 0.1 and a significant increase of the latency to approach 
LL: F[2, 68] = 5.783, P < 0.05. Treatment with both AMPH and 
RO-5203648 caused a trend toward reduction to approach LL: 
F[3, 102] = 2.577, 0.05 < P < 0.1.
LL Preference
As expected, there was a strong effect of delay on LL preference 
for all three genotypes. At higher delays, there was a significant 
reduction in LL preference: F[2, 68] = 44.597, P < 0.0001. This 
reduction was, however, less pronounced when considering only 
KO rats: F[2, 4] = 2.133, 0.05 < P < 0.1. In other terms, KO rats 
showed a higher preference for LL throughout the whole test-
ing phase: F[2, 34] = 6.644, P < 0.05 (Figure 3A). There was a 
significant effect of treatment, especially AMPH, on reducing LL 
preference: F[3, 102] = 8.611, P < 0.0001. This effect was stronger 
in WT, slightly less pronounced in DAT–HET, and absent in KO 
rats: F[3, 6] = 2.448, P < 0.05 (Figure 3B). This drug effect was 
evident at all delays; however, although there was no significant 
treatment by delay interaction, post hoc analyses revealed differ-
ential extent of AMPH effects: in WT rats, AMPH-decreased LL 
preference emerged at 15 and 30 s, but not at 45 s; in DAT–HET 
rats, AMPH-decreased LL preference emerged at 45 and 30 s, but 
not at 15 s (Tukey’s HSD, Ps < 0.05). Therefore, WT rats seem 
to show some tolerance to AMPH effects at a 45-s delay, which 
can well be interpreted as a floor effect, whereas DAT–HET rats 
seemed conversely to display sensitization at a 45-s delay, which 
can well be interpreted as a subchronic effect.
Number of Trials
Knockout rats showed a significantly lower number of total 
effective nose-pokes (i.e., in both holes) when compared to both 
WT and DAT–HET: F[2, 34] = 27.599, P < 0.0001. There was 
also a significant effect of delay on the number of total trials: 
while KO rats showed a significant decrease of trials at higher 
FIGURE 3 | Percentage preference for a large-and-late (LL) reward over a small-and-soon (SS) one in an operant Intolerance-to-Delay Task. (A) Preference for  
LL at increasing delays after the administration of different drugs. Whereas preference for LL decreases significantly at higher delays, knockout (KO) rats show a 
significantly higher preference for LL when compared to both wild-type (WT) and dopamine transporter–heterozygous (HET) rats. Amphetamine (AMPH) reduces 
significantly LL preference in WT rats at all three delays. *P < 0.05. (B) The effect of the different drugs on LL preference (average value collapsed across delays). 
WT rats, after AMPH administration, show a significantly reduced LL preference compared to the saline, vehicle, and RO-5203648 groups. **P < 0.0001.
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delays, WT rats conversely showed an increase of trials: F[4, 
68]  =  12.758, P  <  0.0001 (Figure  4C). Treatment, especially 
AMPH, caused a reduction of total trials at low delays (15  s), 
while it caused an increase of total trials at higher delays (30 
and 45  s): F[6, 204] =  6.105, P <  0.0001 independently from 
genotype. KO rats performed fewer SS trials than both WT and 
DAT–HET: F[2, 34] = 12.947, P < 0.0001. This is consistent with 
the overall enhanced LL preference in this genotype. There was 
also a significant genotype by delay interaction: F[4, 68] = 9.878, 
P < 0.0001, as such scarcity became even more pronounced at 
FIGURE 4 | Other parameters from the Intolerance-to-Delay Task. (A) Total small-and-soon (SS) trials at increasing delays. While there is a clear increase of the 
number of SS trials at higher delays in wild-type (WT) and dopamine transporter (DAT)–heterozygous (HET) rats, knockout (KO) rats did not show such an increase. 
**P < 0.0001. (B) The effect of the different drugs on the total SS trials. The administration of amphetamine (AMPH) on WT and DAT–HET rats has a significant effect 
to increase the total SS trials, if compared to saline, vehicle, and RO-5203648. *P < 0.05. (C) Total [SS + large-and-late (LL)] trials performed at all the three delays: 
total trials of KO rats were always significantly lower than those of WT and DAT–HET rats. **P < 0.0001. (D) The total inadequate nose-pokes, performed in both 
nose-poking holes during the timeout (i.e., when without consequences). For WT and DAT–HET rats, the total inadequate nose-pokes significantly increase at higher 
delays; conversely, for KO rats, inadequate nose-pokes significantly decrease at higher delays. *P < 0.05, **P < 0.0001.
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higher delays (Figure 4A). Finally, there was also a significant 
genotype by treatment interaction: F[6, 102] = 4.032, P < 0.05. 
Specifically, AMPH caused an increase of SS nose-pokes in WT 
and DAT–HET rats (Figure 4B). Considering only LL trials, there 
was a significant effect of delay: as expected, higher delays caused 
a reduction in LL trials for all three genotypes: F[2, 68] = 95.766, 
P < 0.0001.
Number of Inadequate Nose-Pokes
As expected, there was a significant increase in the total inad-
equate nose-pokes in both WT and DAT–HET at higher delays, 
while KO showed an opposite trend, with a significant decrease 
of inadequate nose-pokes: F[4, 68]  =  10.096, P  <  0.0001 
(Figure  4D). This generalized decrease in KO nose-poking 
(both inadequate and adequate, see above) was correlated with 
the appearance of noticeable motor stereotypies (sniffing, chew-
ing) aimed at the edges of the magazine (unformal observations 
during a task). This profile seems to suggest that KO rats reacted 
to delay increase with repetitive/compulsive behaviors, rather 
than motoric/impulsive ones. There was a general increase in 
SS inadequate nose-pokes at higher delays: F[2, 68] = 14.856, 
P < 0.0001; however, such an increase interacted with genotype, 
as it was observed only in WT and DAT–HET and not in KO: 
F[4, 68] = 8.045, P < 0.0001. In other words, KO rats did not 
display restlessness at high delays. Treatment, especially AMPH, 
caused a reduction in SS inadequate nose-pokes at lower delays 
(15 s), while it caused an increase of SS inadequate nose-pokes 
at higher delays (30 and 45 s): F[6, 204] = 3.972, P < 0.05. No 
significant genotype by treatment interaction was shown for 
SS inadequate: F[6, 102] =  1.495, P = NS. There was a sig-
nificant decrease in LL inadequate nose-pokes at higher delays: 
F[2, 68] =  14.914, P <  0.0001, and this decrease was much 
more pronounced in KO rats when compared to both WT and 
DAT–HET: F[4, 68] = 4.203, P < 0.05. In other words, KO rats 
FIGURE 5 | Normalized expression rates [knockout (KO)/wild-type (WT)] of tyrosine hydroxylase (TH), trace amine-associated receptor 1 (TAAR1), serotonin 
transporter (Slc6a4), and dopamine receptor 2 (D2), in ventral striatum samples of rats. For each of the assayed genes, there were no significant differences  
in expression levels between WT and KO rats.
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reacted to a delay by showing a choice for LL in the fewer trials 
with no persistence onto LL hole during TO. Treatment, espe-
cially AMPH, caused a significant decrease in LL inadequate 
nose-pokes, for all the three genotypes: F[3, 102] =  10.601, 
P < 0.0001.
Confirmation of Genotype
First of all, we underline that an extensive proof about the 
effectiveness and consequences of DAT-abolished allele(s) can 
be found elsewhere (1). Just by informal observation in the 
home cages, DAT KO rats demonstrate evident hyperactivity, 
with compulsive rearing at the four corners of the cage and 
stereotyped sniffing directed against focal items of the cage 
grid. Also, while other animals are found asleep or resting after 
1 h following the switch on of facility lights, the DAT KO rats 
were always found to be still awake and running around at 
that time.
In our RFLP analysis, the WT genotype undergoes cutting on 
both alleles and produces two low digested bands (104 and 71 
bp); in the DAT–HET genotype, only one of the alleles is cut, 
resulting in one undigested and two digested bands (175, 104, 
and 71 bp); the KO genotype loses all cutting sites on both alleles 
and displays only one undigested band (175 bp). The genotypes 
of all rats used in this study were confirmed twice, from samples 
collected at weaning and at sacrifice.
RT-PCR in Ventral Striatal Samples
mRNA samples used for retrotranscription had a high degree 
of purity, with an OD260/OD280 ratio of about 2. RT-PCR 
analysis did not show any significant differences between WT 
and KO samples in the normalized expression levels (ΔCt) of 
any of the assayed genes: TH: P = 0.52, TAAR1: P = 0.51, SERT: 
P = 0.25, D2: P = 0.48. ΔΔCt values for the four genes were TH: 
1.13 ± 0.08, TAAR1: 1.32 ± 0.06, SERT: 0.81 ± 0.02, and D2: 
0.92 ± 0.06 (Figure 5).
DISCUSSION
Here, we report a preliminary physiological and behavioral pro-
file of DAT KO rats, a new strain generated in IIT (Genova, Italy) 
and neurochemically characterized by the group of Gainetdinov 
et al. (1). The weight difference between KO and both WT and 
DAT–HET rats seems to point to some sort of dwarfism of KO 
rats. KO rats’ average weight is about 60% of both WT and DAT–
HET, but this is clearly not due to differences in food intake, 
since KO rats eat as much as WT and DAT–HET when kept 
ad libitum. This result is consistent with that already obtained in 
DAT KO mice (40). It is still not clear if the dwarfism observed in 
KO rats is caused by an extreme calorie consumption caused by 
abnormal baseline locomotor activity (1), by a lesser amount of 
growth hormone (like that observed in KO mice) (40), by some 
kind of metabolic dysfunction, or by any combination of these 
factors. Because of this weight anomaly, it was necessary to take 
many precautions when applying food restriction. If fed with the 
same amount of food used to keep WT and DAT–HET to 95% of 
their average body weight, KO rats lost weight more rapidly (data 
not shown). Therefore, it was necessary to adjust the food quan-
tity administered daily to KO rats, up to a value which ranged 
between 1.5 and 2 times more than that administered to WT 
and DAT–HET. Despite eating almost double, KO rats tended 
to loose most of these calories quite quickly when compared to 
WT and DAT–HET.
The IDT yielded several unexpected results regarding 
behavioral abnormalities of DAT KO rats. Even before the 
beginning of the test, during the 2vs2 training phase, KO rats 
tended to show a slight preference (i.e., lateralization) for 
one of the two nose-poke holes, whereas WT and DAT–HET 
subjects chose at random level during this training phase. 
Moreover, during the 1vs5 training phase, some KO individu-
als developed an extreme attraction toward LL hole, reaching 
sometimes a 100% preference for such a hole. This is uncom-
mon: preference for the LL hole, when there is no delay yet 
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assigned to the large reward, usually hovers around 85–90%, 
because rats keep a minimum rate of patrolling at the SS hole 
during sessions (36). More surprisingly, some KO individuals 
underwent a similar lateralization, but toward SS hole: two of 
them chose the large reward in less than 10% of total trials 
and were indeed excluded from the analysis. Rats that were 
already lateralized toward SS during the training phase were 
showing little to no interest for LL for the entire duration 
of the task. Therefore, this abnormal extent of lateralization 
seems independent from the magnitude of rewards assigned 
to either of the two holes; this supports the notion that DAT 
KO rats could be somewhat less sensitive to rewarding stimuli 
(or less able to redirect behavior toward them). During the 
3 weeks of ID testing, KO rats showed a great variability for 
almost every parameter analyzed, while WT and DAT–HET 
were instead much more coherent as groups. However, KO as a 
whole showed some unambiguous features: first, the latency to 
approach SS hole was always higher than WT and DAT–HET 
for all sessions throughout the testing phase. Second, at higher 
delays, the total trials (as well as inadequate nose-poking dur-
ing the TO) decreased dramatically in both holes. Third, the 
ones that were strongly lateralized for LL during the training 
phase maintained an abnormal preference for LL even at 
higher delays without switching to SS.
These behaviors were completely different from the ones 
usually observed with rats in this task. WT and DAT–HET, for 
instance, performed as expected: starting from an LL of about 
85% at the end of the 1vs5 training phase, both groups reduced 
their LL preference and eventually switched toward SS, showing 
a normal curve of impulsivity. Moreover, WT and DAT–HET 
rats performed an increasing number of SS trials and of SS 
inadequate nose-pokes at higher delays. These data provide 
an insight on reactions clearly due to the aversive effects of the 
delay: normal subjects experience a sort of “impatience” or 
“frustration” when forced to wait for the LL reward; thus, they 
start to perform both more SS inadequate nose-pokes during the 
TO and more SS trials (i.e., quicker choice after TO has elapsed) 
when the cost of waiting becomes excessive during LL trials with 
a very long delay. KO rats, instead, seem to react to the increas-
ing delay with conspicuous consummatory motor stereotypies 
addressed to the feeding magazine, like sniffing or chewing. 
A reaction of similar fashion happened in the highly appetitive 
food test with the paper cups, which were destroyed by KO 
rats that showed little to no interest for the cheese. As delays 
assigned to LL became higher, KO rats spent increasingly more 
time performing these stereotypies overall reducing the number 
of trials, choosing LL in such few trials, and showing almost no 
inadequate nose-poking. Oral stereotypies are also presumably 
behind the increased latency to approach the SS nose-poke hole. 
When put in the experimental cages, at any stages of the task, 
KO rats often immediately focused on the feeding magazine 
and performed their stereotypies, then nose-poking for the 
first time only after several minutes. To sum it up, DAT KO rats 
did not show an increased impulsivity when compared to WT 
and DAT–HET: rather, they displayed a reduced sensitivity to 
rewarding stimuli, an increased behavioral rigidity, and a num-
ber of compulsive behaviors.
When taking the effect of drugs into account, AMPH reduced 
LL preference and increased number of SS trials in both WT 
and DAT–HET, as expected: indeed, this psychostimulant drug 
makes healthy subjects more impulsive and increases motor 
activity (34, 41). The absence of any noticeable effect of AMPH 
on DAT KO rats is probably due to the lack of DAT, its main 
target. On the other hand, RO-5203648 had only slight and non-
significant effects on KO rats at a 30-s delay, negligibly reducing 
their elevated LL preference. Considering that the main features 
of KO rats seem to be a compulsive and rigid attitude, the effect 
of RO-5203648 would then have been explained with acting on 
TAAR1 but without the interaction with DAT protein. In line of 
theory, RO-5203648 could have been able to modulate compul-
sive symptoms, induced in subjects by a lack of the DAT protein. 
The reduced preference for the bottle containing a sweet solution, 
observed in KO rats, could point to a slight anhedonia. This could, 
in turn, be caused by a reduced sensitivity to the hedonic proper-
ties of the sweet water because of an impaired reward system. It is 
unlikely that these results could have been influenced by a spatial 
preference for one bottle (though likely in DAT KO rats), because 
bottles were counterbalanced and swapped daily.
These results surprisingly contradict the findings from 
a previous study in DAT KO mice (42). As a matter of fact, 
DAT KO mice showed an increased sucrose preference but 
the opposite was true for rats. This discrepancy could be due 
to different sucrose concentrations: it is possible that DAT KO 
rats are instead more sensitive to the sweet solution, and a 14% 
sucrose concentration could have acted as an aversive stimulus. 
However, the hypothesis of a certain form of anhedonia in KO 
rats could also be supported by the results of the highly appetitive 
food test. KO rats indeed had eaten less cheese, similarly because 
of a reduced sensitivity to the rewarding properties of the taste 
of the cheese. Here, however, another unexpected finding was of 
extreme interest: KO rats usually ignored the cheese instead of 
eating it and rather focused on the paper cups, gnawing, eating 
and/or destroying them. For all the rats tested, there was no 
latency to approach the cheese once it was presented in the home 
cage (unformal observations during a task). In other words, even 
if the cheese was quickly approached, KO rats showed no (or very 
little) interest toward this fatty and caloric food and started to 
perform a series of consummatory stereotypies addressed to the 
paper cups. Only after the paper cups were nearly or completely 
destroyed, some KO rats started to eat some of the cheese, while 
others left it utterly untouched.
Thus, KO rats seemed not only less sensitive to rewarding 
stimuli but also more prone to executing consummatory motor 
stereotypies. This piece of finding could well point to altera-
tions in the motivational states of KO rats, but also to a different 
salience assigned to differently meaningful stimuli (i.e., paper 
cups vs appetitive food). Present male DAT KO rats appear 
somewhat disturbed by objects they find around, a notion 
that seems confirmed by an increased marble manipulation 
in a marble-burying test (33) and by a focused perseverative 
gnawing of one given metal bar of the top grid, not seen in 
KO females (unpublished data: informal observation within 
home cages). It is tempting to speculate that the drive to destroy 
objects may show some face validity with the profile of boys 
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suffering from CD. When compared to DAT KO mice, who 
bury less marbles (43), data available at present characterize 
DAT KO rats as subjects who move marbles around with their 
mouth (possibly trying to gnaw them) always with a compulsive 
drive to eliminate them (informal observation by Adinolfi A. 
and Carbone C.; Master Thesis by Adinolfi A., January 2018). 
Such behaviors may reflect fundamental aspects for rat models 
of OCD with comorbid ADHD that are perhaps absent in cor-
responding DAT KO mice.
Present data can be useful to interpret the many stereotyp-
ies that DAT KO rats do have. As far as ADHD is concerned, 
however, these data point to reward deficiency rather than 
impairments in attentional processes. Our hypothesis about 
an increased behavioral rigidity of DAT KO rats seems further 
supported by results of the Spontaneous Alternation Task (1). 
Here, KO rats showed a strong lateralization, as they alternated 
the chosen arms in consecutive trials to less than 50% of times. 
WT and DAT–HET, instead, alternated as expected to more 
than 80% of times. The perseverance in choosing the same arm 
over and over again overlaps the one shown by always choosing 
the very same nose-poke hole in the IDT, with nearly no con-
sideration for the actual outcome in terms of the correspondent 
reward.
Many studies (15, 44) showed that the levels of many pro-
teins (like TH, and receptors D1 and D2) are altered in the 
striatum of DAT KO mice. These studies, however, focused only 
on proteins, while we wanted to ascertain if similar alterations 
in DAT KO rats could be due to changes at a transcriptional 
level. RT-PCR results did not show any relevant difference 
between WT and KO for all the genes tested (TH, D2, SERT, and 
TAAR1), suggesting no alterations for these genes, at least at a 
transcriptional level. Certainly, this finding does not rule out 
the possibility of a difference in the final protein levels of TH, 
D2, SERT, or TAAR1. If future studies will find abnormalities in 
the density of these proteins, like for mice, our present data sug-
gest that they should be due to posttranscriptional alterations. 
It should be noted that the purity of the initial samples, the 
satisfying total RNA concentrations, and the concordance of Ct 
values for each triplicate point to a good quality and yield of the 
procedures. Thus, the lack of differences between WT and KO 
should not be attributed to biases. It is possible, however, that, 
because of the extremely weak expression of TAAR1, a ceiling 
effect could have masked an actual difference between groups. 
A replication test with a bigger number of subjects (or with 
different primers) could yield different results and highlight 
differences not observed in the present paper (or confirm their 
absence).
CONCLUSION
Even though this study was initially conceived to highlight impul-
sive behaviors of DAT KO rats, it revealed a compulsive phenotype 
instead. KO rats are characterized by pervasive consummatory 
motor stereotypies, noticeable both in their home cages and dur-
ing tests and operant tasks. Moreover, they seem affected by a 
strong behavioral rigidity during operant choices. Finally, they 
show a reduced sensitivity for rewarding properties of food and 
sweet fluids, although generalization to other natural stimuli like 
sex or novelty would deserve further work (33). These behavioral 
abnormalities are not associated with alterations in the expression 
levels of some genes correlated with DAT (TH, D2, SERT, and 
TAAR1) in the ventral striatum, although it is possible that the 
final protein levels could actually differ between WT and KO.
Data obtained with this study provided a first phenotypic 
characterization of DAT KO rats. First evidences obtained so far 
[present work; Adinolfi et al. (33); Leo et al. (1)] refer to animals 
of the various genotypes obtained as offspring of DAT–HET 
fathers and mothers. DAT KO rats share many features with DAT 
KO mice: both species present a significant reduction in the total 
striatum DA levels, also compared to HETs (15, 40); both show 
an increased locomotor activity and reduced spontaneous alter-
nation in a Y-maze when compared to WTs (15, 45). However, 
DAT KO rats show a reduced preference to sweet solutions (pre-
sent data) and manipulate the marbles much more in a burying 
test, still showing attentional skills in a novelty-preference test 
(33), while DAT KO mice have an incredibly opposite profile 
(42, 43). Many other works are warranted to define a better 
picture of the behavioral and biochemical alterations which 
affect rats when compared to mice, both lacking the DAT pro-
tein. Clarifying the full extent of neurobehavioral alterations in 
DAT KO rats would be of primary importance to validate them 
as a model of ADHD, OCD, or other similar neuropsychiatric 
diseases, like compulsive behavioral addictions. Their use as 
models in preclinical research is warranted to move steps toward 
the definition of new and innovative therapies to treat human 
conditions, especially in adolescents. Indeed, subjects at this age 
are more vulnerable to malfunctions in the DA circuitry, due 
to their still incomplete brain maturation (particularly within 
the prefrontal cortex) and to the developmental challenges they 
must face: the latter include both the onset of puberty (with its 
significant physical changes) and the important relational and 
psychosocial transitions (46, 47).
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